In this podcast, we discuss three new injectable insulin formations: Toujeo (insulin glargine U-300), Humalog U-200 (insulin lispro), and Tresiba (insulin degludec).
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.